Filter News
Area of Research
- (-) National Security (8)
- (-) Neutron Science (13)
- (-) Nuclear Science and Technology (5)
- Advanced Manufacturing (3)
- Biology and Environment (34)
- Clean Energy (41)
- Computational Biology (1)
- Computational Engineering (1)
- Computer Science (4)
- Fusion and Fission (2)
- Materials (42)
- Materials for Computing (7)
- Quantum information Science (2)
- Supercomputing (37)
News Type
News Topics
- (-) Big Data (8)
- (-) Composites (1)
- (-) Coronavirus (11)
- (-) Microscopy (3)
- (-) Molten Salt (4)
- 3-D Printing/Advanced Manufacturing (12)
- Advanced Reactors (12)
- Artificial Intelligence (18)
- Bioenergy (12)
- Biology (9)
- Biomedical (16)
- Biotechnology (2)
- Buildings (1)
- Chemical Sciences (4)
- Clean Water (2)
- Climate Change (5)
- Computer Science (33)
- Cybersecurity (19)
- Decarbonization (5)
- Energy Storage (8)
- Environment (13)
- Exascale Computing (1)
- Fossil Energy (1)
- Frontier (2)
- Fusion (10)
- Grid (6)
- High-Performance Computing (6)
- Isotopes (5)
- Machine Learning (15)
- Materials (16)
- Materials Science (27)
- Mathematics (1)
- Nanotechnology (11)
- National Security (34)
- Neutron Science (101)
- Nuclear Energy (41)
- Partnerships (4)
- Physics (11)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (8)
- Security (12)
- Simulation (1)
- Space Exploration (8)
- Summit (7)
- Sustainable Energy (5)
- Transformational Challenge Reactor (3)
- Transportation (7)
Media Contacts
Digital twins are exactly what they sound like: virtual models of physical reality that continuously update to reflect changes in the real world.
The Department of Energy’s Office of Science has selected three ORNL research teams to receive funding through DOE’s new Biopreparedness Research Virtual Environment initiative.
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.
When the COVID-19 pandemic stunned the world in 2020, researchers at ORNL wondered how they could extend their support and help
It’s a simple premise: To truly improve the health, safety, and security of human beings, you must first understand where those individuals are.
A team of researchers has developed a novel, machine learning–based technique to explore and identify relationships among medical concepts using electronic health record data across multiple healthcare providers.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
At the Department of Energy’s Oak Ridge National Laboratory, scientists use artificial intelligence, or AI, to accelerate the discovery and development of materials for energy and information technologies.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.